CH de Libourne — Libourne

What best describes you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of CH de Libourne, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Post-Traumatic Stress Disorder · Arthritis, Rheumatoid · Multiple Myeloma · Myeloproliferative Neoplasm

Recently updated registry entries

NCT04196868 — Methotrexate and Metformin in Rheumatoid Arthritis Patients (Completed)
NCT05098704 — Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk (Recruiting)
NCT03296202 — Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in… (Active Not Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 08, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.